Paclitaxel in combination with cisplatin is less effective for peripheral blood progenitor cell mobilization

International Journal of Gynecological Cancer

Volumn 10, Issue 6, 2000, Pages 459-462

  Kurata, Hitoshi ^a   Takakuwa, K ^a   Tsuneki, I ^a   Aoki, Y ^a   Tanaka, K ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

Cisplatin; G CSF; Paclitaxel; PBPC collection

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; PACLITAXEL; PEPLEOMYCIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; CANCER CHEMOTHERAPY; CELL COUNT; CELL MOTILITY; CLINICAL ARTICLE; CLINICAL TRIAL; COLONY FORMING UNIT GM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GYNECOLOGIC CANCER; HUMAN; PRIORITY JOURNAL; STEM CELL;

EID: 0034500035     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.2000.00075.x     Document Type: Article

References (10)

1. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
2. A simplified method for cryopreservation of peripheral blood stem cells at -80°C without rate-controlled freezing
3. Mobilization of peripheral blood progenitor cells with paclitaxel-based chemotherapy
4. A phase I study of paclitaxel for mobilization of peripheral blood progenitor cells
5. Peripheral-blood stem-cell collection after paclitaxel, cyclophosphamide, and recombinant human granulocyte colony-stimulating factor in patients with breast and ovarian cancer
6. Collection of peripheral blood stem cells following administration of paclitaxel, cyclophosphamide, and filgrastim in patients with breast and ovarian cancer
7. Collection of circulating progenitor cells after epirubicin, paclitaxel and filgrastim in patients with metastatic breast cancer
8. Mobilization, collection, and characterization of peripheral blood hemopoietic progenitors after chemotherapy with epirubicin, paclitaxel, and granulocyte-colony stimulating factor administered to patients with metastatic breast carcinoma
9. Ifosfamide in combination with paclitaxel or doxorubicin: Regimens which effectively mobilize peripheral blood progenitor cells while demonstrating anti-tumor activity in patients with metastatic breast cancer
10. Factors influencing collection of peripheral blood progenitor cells following high-dose cyclophosphamide and granulocyte colony-stimulating factor in patients with multiple myeloma